LAP TGF-beta-1 is an anti-inflammatory cytokine that was independently associated with Alzheimer’s disease in our study (OR [95% CI]: 1.46 [1.21–1.76]). Here, TGFB1 is linked to early-onset autosomal dominant Alzheimer disease.